There’s a problem with inspiration.
You spend two days at Pharmageddon. You hear ideas that make you question how things work, having conversations you’d never risk at the office, and start imagining a pharma world that doesn’t make you sigh at your coffee. Maybe you even make notes, underline, draw a star or two. We see you.
Then you go home.
The inbox is waiting. Someone needs a deck. Your next meeting starts in ten minutes. And by Wednesday, the thing you were absolutely going to do something about has become a half-remembered note in the corner of your notebook.
That’s why we introduced Day Three.
The first morning you’re back at your desk is when the ideas from Pharmageddon have to survive contact with your actual organisation. We don’t want the event to be something you enjoyed for two days and then struggled to explain to your colleagues… but it should make them envious they didn’t attend.
But here’s the twist.
Day Three doesn’t really start when you leave Amsterdam. It starts while you’re still in the room.
So we’ve built three tools to help you get more from the two days, and make more of what happens afterwards.
The Rounds
First, there’s the small matter of taking useful notes.
We’ve all been to conferences where we’ve left with pages of notes and absolutely no idea what to do with them. The problem isn’t necessarily how much you write down. It’s whether you’re capturing the things that will still matter when you’re back at your desk.
The Rounds is your cheat sheet for notes that helps you stay in the room and actually remember ideas, questions, disagreements and connections. The bits you’ll want later. Think of it less as a note-taking system and more as a way of deciding what to listen for, plus some reflection questions for the end of each day.
The Outpatient Plan
At the end of Pharmageddon, you’ll have a treatment plan: a set of ideas about what pharma needs to do differently.
That’s deliberately big. The harder question is what any of it means for your organisation.
The Outpatient Plan is designed to help you make that leap.
It’s a series of prompts that follows the treatment plan and asks you to make it specific. What did Pharmageddon make you question? Where does that problem show up in your organisation? What could you actually change? Who needs to be involved? And what are you prepared to do about it?
You won’t have all the answers, and you’re not expected to. The point is to start turning a big idea about the future of pharma into something you could actually take back to work.
[Explore The Outpatient Plan →]
Facilitated Disucssions
Then comes the hardest bit: getting other people involved.
It’s one thing to leave Pharmageddon with an idea. It’s another to explain why it matters to someone who wasn’t there, and get them to think about it with you.
Facilitated Discussions are three frameworks to make that less painful. Use them to reflect, argue, or get a group to actually make a decision. Miracles do happen.
You don’t need to become a facilitator or follow the frameworks word for word. They’re there to give you some structure when a good conversation needs a little more than “so, what did everyone think?”
Because a good idea is only useful if it goes somewhere.
[Explore Facilitated Discussions →]
Day Three starts now
These tools are deliberately simple, and you don’t need to use all of them.
We’ve heard the feedback that Pharmageddon can feel too aspirational. We took that seriously. But the answer isn’t to make the event less ambitious. It’s to build a better bridge between the ideas we explore together and the organisations we’re all going back to.
That’s why we’re giving you these tools before you arrive in Amsterdam.
Have a look at them. Bring them into the room. Use them when they’re useful. Scribble on them, ignore bits, share them with the person next to you.
There is no test. There is no prize for completing all three.
We just want the useful stuff to survive the journey home.
We want you to leave with a few things you can’t quite shake, and a pretty good idea of what you’re going to do about them.